The University of Oxford has started the phase 1 clinical trials on 54 healthy adults to investigate intranasal inoculation with the vaccine it developed with AstraZeneca (ChAdOx1 nCoV-19/AZD1222) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results